EverSource Wealth Advisors LLC Grows Stake in DaVita Inc. (NYSE:DVA)

EverSource Wealth Advisors LLC raised its holdings in shares of DaVita Inc. (NYSE:DVA) by 110.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,803 shares of the company’s stock after purchasing an additional 946 shares during the period. EverSource Wealth Advisors LLC’s holdings in DaVita were worth $246,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Norges Bank acquired a new stake in DaVita in the 4th quarter worth approximately $36,626,000. Corient Private Wealth LLC grew its holdings in shares of DaVita by 546.9% during the fourth quarter. Corient Private Wealth LLC now owns 27,977 shares of the company’s stock valued at $2,931,000 after buying an additional 23,652 shares during the last quarter. Quest Partners LLC acquired a new position in shares of DaVita in the 4th quarter valued at $74,000. Franklin Resources Inc. raised its stake in DaVita by 42.0% in the 4th quarter. Franklin Resources Inc. now owns 7,866 shares of the company’s stock worth $824,000 after acquiring an additional 2,325 shares during the last quarter. Finally, Advisory Services Network LLC acquired a new stake in DaVita during the 4th quarter worth about $385,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on DVA. StockNews.com downgraded DaVita from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 8th. TD Cowen increased their price objective on shares of DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a research note on Wednesday, July 24th. Truist Financial boosted their target price on shares of DaVita from $150.00 to $165.00 and gave the company a “hold” rating in a research report on Tuesday, August 20th. UBS Group increased their price target on DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Finally, Bank of America boosted their price objective on DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a report on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $157.00.

Insider Buying and Selling

In other news, CEO Javier Rodriguez sold 32,176 shares of DaVita stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $155.93, for a total value of $5,017,203.68. Following the sale, the chief executive officer now owns 905,659 shares in the company, valued at $141,219,407.87. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, insider Kathleen Alyce Waters sold 7,857 shares of the stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total value of $1,148,771.97. Following the completion of the transaction, the insider now directly owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Javier Rodriguez sold 32,176 shares of DaVita stock in a transaction on Monday, August 26th. The stock was sold at an average price of $155.93, for a total transaction of $5,017,203.68. Following the sale, the chief executive officer now directly owns 905,659 shares in the company, valued at approximately $141,219,407.87. The disclosure for this sale can be found here. In the last quarter, insiders sold 173,482 shares of company stock valued at $27,387,069. 2.00% of the stock is owned by corporate insiders.

DaVita Trading Up 1.5 %

Shares of DaVita stock opened at $164.06 on Thursday. DaVita Inc. has a fifty-two week low of $71.51 and a fifty-two week high of $166.04. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16. The company has a market cap of $13.76 billion, a P/E ratio of 18.64, a price-to-earnings-growth ratio of 0.93 and a beta of 0.87. The firm has a 50-day simple moving average of $149.11 and a two-hundred day simple moving average of $141.76.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $2.59 EPS for the quarter, beating the consensus estimate of $2.47 by $0.12. The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.15 billion. DaVita had a return on equity of 77.00% and a net margin of 6.86%. DaVita’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period last year, the company earned $2.08 earnings per share. As a group, equities analysts predict that DaVita Inc. will post 9.99 earnings per share for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.